These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab. Moltó A; Mateo L; Lloveras N; Olivé A; Minguez S Joint Bone Spine; 2010 May; 77(3):271-3. PubMed ID: 20378385 [TBL] [Abstract][Full Text] [Related]
3. Visceral Leishmaniasis among immunosuppressed patients with rheumatic diseases. Erre GL; Mesina P; Tonelli N; Passiu G Clin Exp Rheumatol; 2010; 28(4):590-1. PubMed ID: 20659417 [No Abstract] [Full Text] [Related]
4. [Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: a case description and literature review]. Moreno D; Martínez P; Berbegal J; Femenia M Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):261-2. PubMed ID: 19729230 [No Abstract] [Full Text] [Related]
5. Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature. Català A; Roé E; Dalmau J; Pomar V; Muñoz C; Yelamos O; Puig L Dermatology; 2015; 230(3):204-7. PubMed ID: 25633623 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab. Gomes KW; Benevides AN; Vieira FJ; Burlamaqui MP; Vieira Mde A; Fontenelle LM Rev Bras Reumatol; 2012; 52(3):447-52. PubMed ID: 22641598 [TBL] [Abstract][Full Text] [Related]